<DOC>
	<DOCNO>NCT02598635</DOCNO>
	<brief_summary>Aim : To investigate whether cholecalciferol ( 4800 U/daily ) placebo 16 week reduce protein level associate vascular calcification ( osteoprotegerin , osteopontin , osteocalcin ) patient treat peritoneal dialysis 25 ( OH ) vitamin D deficiency .</brief_summary>
	<brief_title>Effects Cholecalciferol Osteoprotegerin Levels Patients Peritoneal Dialysis</brief_title>
	<detailed_description>Patients chronic kidney disease peritoneal dialysis low 25- ( OH ) vitamin D level . Vitamin D deficiency may involve generalized atherosclerosis , vascular calcification cardiovascular mortality . Among others , Osteoprotegerin ( OPG ) implicate pathogenesis lead vessel calcification patient . Furthermore , low level 25- ( OH ) vitamin D peritoneal dialysis patient associate increased level OPG high value vascular calcification score x-ray . It unknown whether cholecalciferol supplementation patient peritoneal dialysis low level 25- ( OH ) vitamin D could change protein associate vascular calcification . The objective conduct randomize , double-blind , placebo-controlled study focus impact Cholecalciferol substitution 25-OH vitamin D deficient peritoneal dialysis patient circulate OPG osteogenic biomarkers level 16 week intervention . Moreover , impact cholecalciferol serum calcium phosphorus level , Kidney Disease Quality Life Short Form , ultrasound characteristic carotid arterial perform first four week inclusion , 28 week postintervention . Peritoneal dialysis patient find 25- ( OH ) vitamin D level &lt; 20 ng/ml include randomized receive either oral cholecalciferol therapy placebo . Cholecalciferol administer daily dose 4800 IU time period 16 week . All , 58 subject include study .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Peritoneal dialysis treatment least 3 month . Concentrations 25oh vitamin D &lt; 20 ng / mL Corrected calcium &lt; 10.5 mg / dL Serum phosphorus &lt; 7.0 mg / dL Intact parathyroid hormone &gt; 50 pg / mL &lt; 1500 pg/mL Active participation another protocol . Vitamin D deficiency due hereditary disease liver disease . Use cholecalciferol â‰¥ 2000 IU per day within 6 month prior New prescription calcitriol paricalcitol dose within three month prior intervention ( The subject may take calcitriol paricalcitol drug take least three month substantial change dosage make ) . Use bisphosphonates . Treatment anticonvulsant drug affect metabolism vitamin D. Pregnancy lactation . Active cancer active inflammatory disease . HIV AIDS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cholecalciferol</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>FGF23</keyword>
	<keyword>Calcium</keyword>
	<keyword>Phosphorus</keyword>
</DOC>